Conconi et al., Outcome analysis of diffuse large B‐cell lymphoma among people living with HIV and competent individuals
Population‐based outcome analysis of diffuse large B ‐cell lymphoma in people living with HIV infection and competent individuals. Hematological Oncology Conconi et al. aimed to compare the clinical features, prognostic variables, and the clinical outcome of a series of consecutive acquired immunodeficiency syndrome related diffuse large B‐cell lymphoma (AR‐DLBCL) patients from the Swiss HIV […]
Kusejko et al., Inferring the age difference in HIV transmission pairs
Inferring the age difference in HIV transmission pairs by applying phylogenetic methods on the HIV transmission network of the Swiss HIV Cohort Study. Virus Evolution Kusejko et al. aimed to study the age difference at infection in HIV transmission pairs using phylogenetic methods. The authors used HIV-1 pol-sequences of 11’922 Swiss HIV Cohort Study (SHCS) […]
Sabin et al., Abacavir and recurrent myocardial infarction
Abacavir use and risk of recurrent myocardial infarction. AIDS Sabin et al. on behalf of the D:A:D study group aimed to investigate the association between abacavir use and subsequent myocardial infarction risk among the patients who had already experienced an myocardial infarction during prospective D:A:D follow-up. Nine-hundred-eighty-four individuals experienced an index myocardial infarction during […]
Kouyos et al., Imprinting broadly neutralizing antibody responses
Tracing HIV-1 strains that imprint broadly neutralizing antibody responses. Nature Kouyos et al. aimed to identify the viral determinants of a broadly neutralizing immune response in HIV-infected humans. The study-hypothesis was that if viral factors determine the quality of the antibody response, individuals with closely related viral strains would have similar neutralization responses. The […]
Ryom et al., Cardiovascular disease and use of contemporary protease inhibitors
Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort study. Lancet HIV Ryom et al. on behalf of the D:A:D study aimed to assess whether cumulative use of ritonavir-boosted atazanavir and ritonavir-boosted darunavir was associated with increased incidence of cardiovascular disease in people living with HIV. Participants were monitored from […]
Salazar-Vizcaya et al., Impact of DAA on the burden of HCV in the SHCS
Impact of direct-acting antivirals on the burden of HCV infection among persons who inject drugs and men who have sex with men in the Swiss HIV Cohort Study. Open Forum Infectious Diseases Salazar-Vizcaya et al. aimed to describe and compare direct-acting antivirals (DAA) upscale and its impact on the number of replicating hepatitis C virus […]
Kusejko et al., Drivers of the HIV epidemic in MSM
Quantifying the drivers of HIV transmission and prevention in men who have sex with men: a population model-based analysis in Switzerland. HIV Medicine Kusejko et al. aimed to identify and quantify the drivers of the HIV epidemic of men who have sex with men (MSM) in Switzerland and to assess the potential impact of […]
Peters et al., Direct-acting antivirals in HIV/hepatitis C virus patients
Uptake of HCV treatment in HIV/HCV coinfected patients across europe in the era of direct-acting antivirals. AIDS Peters et al. the EuroSIDA Study Group aimed to investigate regional differences in the rate of hepatitis C virus (HCV) treatment uptake, and type of therapy used among HIV/HCV-coinfected patients in the pan-European Euro-SIDA study between 2011 […]
Kusejko et al., Causes de l’épidémie VIH chez les HSH participant à la SHCS
Causes de l’épidémie VIH chez les hommes qui ont des rapports sexuels avec des hommes et qui participent à la SHCS. HIV Medicine Les hommes qui ont des rapports sexuels avec des hommes (HSH) représentent en Suisse le principal groupe à risque pour la transmission du VIH. Afin de pouvoir contrôler cette épidémie il […]
Kusejko et al., Cause dell’epidemia HIV negli MSM che partecipano alla SHCS
Cause dell’epidemia HIV negli uomini che hanno rapporti sessuali con uomini e che partecipano alla SHCS. HIV Medicine Gli uomini che hanno rapporti sessuali con altri uomini (MSM) rappresentano in Svizzera il principale gruppo a rischio per la trasmissione dell’HIV. Per poter controllare questa epidemia è importante conoscere l’efficacia delle misure di prevenzione mirata. […]